Candesartan Cilexetil
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3063 publications
Superior outcomes of candesartan over topiramate in the treatment of migraine: A comparative cohort study.
Journal: Cephalalgia : an international journal of headache
Published: March 04, 2026
The effect of multidisciplinary open-label treatment in patients with persistent post-traumatic headache at two tertiary headache centers.
Journal: Pain management
Published: February 28, 2026
Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates.
Journal: Ageing research reviews
Published: February 24, 2026
The angiotensin II receptor blocker candesartan mitigates cisplatin-induced myocardial injury via suppression of TLR-4/NF-κB/IRF-3/AP-1 signaling and restoration of antioxidant defenses.
Journal: Tissue & cell
Published: January 26, 2026
Microbial Metabolite 4EPS Inhibits AT1R to Reduce Blood Pressure and Aortic Aneurysm Outcome.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 22, 2026
Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.
Journal: Translational and clinical pharmacology
Published: December 29, 2025
Decoding the Neuroprotective Intervention of Angiotensin Receptor Blockers: A Multimodal Approach Using In Silico Network Pharmacology, Molecular Modeling, and In Vivo Validation of Key Markers.
Journal: ACS chemical neuroscience
Published: December 11, 2025
A systematic review of commencing full-dose antihypertensives in newly diagnosed hypertension.
Journal: Blood pressure
Published: December 06, 2025
Long-term risk of dementia with angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive patients: A 15-year follow-up using the 45 and Up Study.
Journal: GeroScience
Published: December 03, 2025
Unique gut microbiota and metabolomic profiling as biomarker of post-transplant recovery in acute-on-chronic liver failure after liver transplantation.
Journal: Applied microbiology and biotechnology
Published: December 01, 2025
The First Russian Fixed Combination of Indapamide Retard and Candesartan: Results of Two Pharmacokinetic and Bioequivalence Studies.
Journal: Kardiologiia
Published: November 13, 2025
Last Updated: 04/28/2026